Sun Pharmaceutical Industries (SUNPHARMA) Share Price Falls 2.1% in Large Cap Pharma Sell-Off
- September 30, 2026
- Posted by: Kunal Singla
- Category: News
Sun Pharmaceutical Industries Share Price was at Rs 1,821, down 2.1% from the previous close, with the company valued at Rs 4,41,477.63 crore as a Large Cap. The move matters because Sun Pharmaceutical Industries Share Price is one of the most closely tracked names in the healthcare pack, and today’s decline places immediate attention on valuation, sector positioning and the latest trading setup around the stock. According to Univest data, the share price fall comes after a gap higher open was not sustained, and the stock moved lower through the morning session. For readers following Sun Pharmaceutical Industries Share Price Today, the session also brings the company’s fundamental profile into focus, including its earnings quality, return ratios and premium pricing relative to the broader pharmaceuticals universe.
Sun Pharmaceutical Industries (SUNPHARMA) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,821 |
| Previous Close | Rs 1,860 |
| Today's Move | -Rs 39.00 (-2.1%) |
| Open | Rs 1,867.75 |
| High | Rs 1,867.75 |
| Low | Rs 1,813.5 |
| Market Capitalisation | Rs 4,41,477.63 crore |
| Market Cap Category | Large Cap |
Sun Pharmaceutical Industries Share Price opened at Rs 1,867.75, touched a high of Rs 1,867.75 and a low of Rs 1,813.5, before trading at Rs 1,821 as of 30 September 2026 at 10:53:17 AM IST. The stock was down Rs 39 from the previous close of Rs 1,860, which translates into a 2.1% decline in Sun Pharmaceutical Industries Share Price Today. With a market capitalisation of Rs 4,41,477.63 crore, the company sits in the Large Cap category, so its price action is watched not only as a stock-specific event but also as a key healthcare market indicator. Sun Pharmaceutical Industries Share Price moved within a relatively tight intraday band, and that keeps the focus on what the valuation and financial ratios say next.
Why Sun Pharmaceutical Industries (SUNPHARMA) May Be Moving Today
Sun Pharmaceutical Industries (SUNPHARMA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 4,41,477.63 crore |
| P/E Ratio | 36.9x |
| P/B Ratio | 5.16x |
| ROE | 14.85% |
| ROCE | 19.11% |
| EPS | Rs 50.41 |
| Book Value Per Share | Rs 360.44 |
| Dividend Yield | 0.86% |
Sun Pharmaceutical Industries Share Price is supported by a large balance of scale and profitability metrics, but the valuation remains important in any stock analysis. The company has a market cap of Rs 4,41,477.63 crore, an enterprise-scale presence in healthcare, and a P/E ratio of 36.9 with a P/B ratio of 5.16. Its ROE stands at 14.85% and ROCE at 19.11%, which shows the business is generating healthy returns on capital employed. EPS is Rs 50.41, book value is Rs 360.44 and dividend yield is 0.86%, all of which give context to Sun Pharmaceutical Industries Share Price. In simple terms, Sun Pharmaceutical Industries Share Price is backed by solid profitability, but the valuation is still rich enough that investors tend to weigh every move in Sun Pharmaceutical Industries Share Price Today carefully. For Univest readers tracking Sun Pharmaceutical Industries Fundamental Analysis, the key point is that the stock combines scale, profitability and premium pricing in one large cap healthcare name.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 36.9x |
| Benchmark Median P/E | 32.43x |
| Benchmark Average P/E | 49.46x |
| Benchmark P/E Range | 3.4x to 699.02x |
| Company P/B Ratio | 5.16x |
| Benchmark Median P/B | 2.89x |
| Benchmark Average P/B | 4.38x |
| Company ROE | 14.85% |
| Benchmark Median ROE | 11.7% |
| Benchmark Average ROE | 10.68% |
| Company ROCE | 19.11% |
| Benchmark Median ROCE | 13.61% |
| Benchmark Average ROCE | 13.4% |
| Company Market Capitalisation | Rs 4,41,477.63 crore |
| Benchmark Median Market Cap | Rs 776.09 crore |
| Benchmark Average Market Cap | Rs 14,255.4 crore |
Sun Pharmaceutical Industries Share Price should be read against the broader healthcare and pharmaceuticals backdrop, where valuation dispersion is wide. In the same industry benchmark of 199 companies, Sun Pharmaceutical Industries Share Price trades at a P/E of 36.9 versus a benchmark median of 32.43 and an average of 49.46. Its P/B of 5.16 is above the benchmark median of 2.89 and above the average of 4.38, while ROE at 14.85% is above the median of 11.7% and the average of 10.68%. ROCE at 19.11% also stands above the benchmark median of 13.61% and average of 13.4%. The benchmark market cap median is Rs 776.09 crore and the average is Rs 14,255.4 crore, which shows how far Sun Pharmaceutical Industries Share Price sits above the typical company in the same industry scope. In sector analysis, this places Sun Pharmaceutical Industries Share Price among the more valuable healthcare names, with performance judged against both scale and return metrics rather than size alone. For investors following Sun Pharmaceutical Industries Share Price Today, the comparison suggests a premium large cap pharma profile within a broad pharmaceuticals universe.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Divi's Laboratories | DIVISLAB | 2,53,031.38 | 85.99 | 14.24 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,85,216.32 | 85.72 | 20.83 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,20,897.46 | 26.42 | 4.42 | 19.69 | 21.39 |
| Cipla | CIPLA | 1,12,205.15 | 33.15 | 3.18 | 11.83 | 16 |
| Laurus Labs | LAURUSLABS | 1,08,710.82 | 98.12 | 19.03 | 18.31 | 18.2 |
Sun Pharmaceutical Industries Share Price can also be compared with listed peers in the same industry. Against Divi’s Laboratories at a P/E of 85.99 and market cap of Rs 2,53,031.38 crore, Sun Pharmaceutical Industries Share Price looks less expensive on earnings and carries a larger market cap. Against Torrent Pharmaceuticals, which has a P/E of 85.72 and ROE of 26.76%, Sun Pharmaceutical Industries Share Price again trades at a lower earnings multiple but also posts a lower ROE. Zydus Lifesciences has a P/E of 26.42, below Sun Pharmaceutical Industries Share Price, while its ROE of 19.69% and ROCE of 21.39% sit above Sun Pharmaceutical Industries Share Price on both return measures. Cipla shows a P/E of 33.15 and market cap of Rs 1,12,205.15 crore, which makes Sun Pharmaceutical Industries Share Price more expensive on earnings but far larger in scale. The peer set shows Sun Pharmaceutical Industries Share Price as a premium large cap with strong returns, though not the highest-return stock in the group.
Why Investors Are Watching Sun Pharmaceutical Industries
- Sun Pharmaceutical Industries Share Price is down 2.1% today, so traders are watching how the morning range develops around Rs 1,821.
- The Large Cap market capitalisation keeps Sun Pharmaceutical Industries Share Price important for healthcare market sentiment.
- The P/E of 36.9 and P/B of 5.16 place Sun Pharmaceutical Industries Share Price at a premium to the broader industry median.
- ROE of 14.85% and ROCE of 19.11% give Sun Pharmaceutical Industries Share Price a profitability backdrop that stands above the industry median.
- Peer comparison shows Sun Pharmaceutical Industries Share Price is priced below some high-multiple pharma names but above several mid-range peers.
About Sun Pharmaceutical Industries
Sun Pharmaceutical Industries operates in the Pharmaceuticals & Drugs industry within the Healthcare sector. The company is one of India’s most prominent pharmaceutical businesses and is followed closely for its scale, product breadth and large cap profile. Its business is centred on medicines and healthcare products, and Sun Pharmaceutical Industries Share Price tends to reflect both operating scale and valuation expectations in the pharma space. For readers tracking Sun Pharmaceutical Industries Share Price Today, the company’s market position makes it a core name in healthcare discussions, especially when sector policy and pricing questions enter the market conversation. Sun Pharmaceutical Industries Stock News often matters because the stock sits at the intersection of defensive sector demand and premium earnings multiples.
Track Sun Pharmaceutical Industries Share Price on Univest
Use Sun Pharmaceutical Industries (SUNPHARMA) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
Readers can track Sun Pharmaceutical Industries Share Price on Univest for live market updates, valuation ratios, 52-week levels and broader stock insights. The platform also helps users compare Sun Pharmaceutical Industries Share Price Today with peer names, review key ratios and follow healthcare market context in one place. For anyone studying Sun Pharmaceutical Industries Share Price Update or Sun Pharmaceutical Industries Stock Analysis, Univest provides a straightforward way to monitor the stock alongside its fundamental profile.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
What is Sun Pharmaceutical Industries Share Price today?
Ans. Sun Pharmaceutical Industries Share Price was at Rs 1,821, down 2.1% from the previous close of Rs 1,860. The stock moved within Rs 1,813.5 to Rs 1,867.75 during the session.
Why is Sun Pharmaceutical Industries Share Price falling today?
Ans. According to recent news reports, a Supreme Court proposal for a uniform 16% retail markup cap on medicines may be relevant.
What does Sun Pharmaceutical Industries Share Price tell investors?
Ans. Sun Pharmaceutical Industries Share Price reflects a large cap pharma business with a market cap of Rs 4,41,477.63 crore, a P/E of 36.9 and a P/B of 5.16, which keeps valuation central to the discussion.
How does Sun Pharmaceutical Industries compare with its peers?
Ans. Sun Pharmaceutical Industries Share Price trades below Divi's Laboratories and Torrent Pharmaceuticals on P/E, but above Zydus Lifesciences and Cipla. Its market cap is also the largest among the listed peer set here.
Is Sun Pharmaceutical Industries Share Price expensive compared with the industry?
Ans. Sun Pharmaceutical Industries Share Price has a P/E of 36.9, above the industry median of 32.43 and below the industry average of 49.46. Its P/B of 5.16 is also above the benchmark median.
What profitability ratios matter for Sun Pharmaceutical Industries?
Ans. Sun Pharmaceutical Industries Share Price is supported by ROE of 14.85% and ROCE of 19.11%. These figures are above the industry medians, which helps explain why the stock attracts regular attention in healthcare.
What are the key valuation metrics for Sun Pharmaceutical Industries Share Price?
Ans. The main metrics are P/E at 36.9, P/B at 5.16, EPS at Rs 50.41, book value at Rs 360.44 and dividend yield at 0.86%. Together they define the valuation backdrop.
Should investors track Sun Pharmaceutical Industries Share Price on Univest?
Ans. Yes, because Univest brings together Sun Pharmaceutical Industries Share Price Today, valuation ratios, peer comparison and market-cap context. That combination makes it easier to follow the stock without relying on fragmented market updates.
